Hypermethylation of the ADIRF promoter regulates its expression level and is involved in NNK-induced malignant transformation of lung bronchial epithelial cells
Authors:
- 1 October 2023
- journal article
- research article
- Published by Springer Nature in Archives of Toxicology
- Vol. 97 (12) , 3243-3258
Abstract
The carcinogenic mechanism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a well-known tobacco carcinogen, has not been fully elucidated in epigenetic studies. 5-Methylcytosine (5mC) modification plays a major role in epigenetic regulation. In this study, the 5mC level increased in both BEAS-2B human bronchial epithelium cells treated with 100 mg/L NNK for 24 h and NNK-induced malignant-transformed BEAS-2B cells (2B-NNK cells), suggesting that 5mC modification is associated with the malignant transformation mechanism of NNK. Using a combination of Methylated DNA Immunoprecipitation Sequencing (MeDIP-seq), RNA sequencing (RNA-seq), and bioinformatics analysis of data from the Genomic Data Commons database, we found that the Adipogenesis regulatory factor (ADIRF) promoter region was abnormally hypermethylated, yielding low ADIRF mRNA expression, and that ADIRF overexpression could inhibit the proliferation, migration, and invasion of 2B-NNK cells. This finding suggests that ADIRF plays a tumor suppressor role in the NNK-induced malignant transformation of cells. Subsequently, using 5-Aza-2’-deoxycytidine (5-Aza-2’-dC) and the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Catalytically Dead Cas9 (dCas9 system), we verified that the demethylation of the ADIRF promoter region in 2B-NNK cells inhibited the proliferation, migration, and invasion ability of the cells and increased their apoptosis ability. These results suggest that abnormal 5mC modification of the ADIRF promoter plays a positive regulatory role in the pathogenesis of NNK-induced lung cancer. This study offers a new experimental basis for the epigenetic mechanism of NNK-induced lung cancer.Keywords
Funding Information
- Natural Science Foundation of Guangdong Province (2022A1515010727)
- Qinghai Provincial Key Laboratory of Tibetan Medicine Research (2022ZDZX2047)
- Key Research and Development Programme of Guangzhou Science and Technology Project (202206010061)
This publication has 52 references indexed in Scilit:
- Influence of natural killer cells and perforin-mediated cytolysis on the development of chemically induced lung cancer in A/J miceCancer Immunology, Immunotherapy, 2014
- Discovery Analysis of TCGA Data Reveals Association between Germline Genotype and Survival in Ovarian Cancer PatientsPLOS ONE, 2013
- DNA Demethylation by TDGEpigenomics, 2012
- Epigenetic Drug Discovery: Targeting DNA MethyltransferasesSLAS Discovery, 2012
- The tobacco-specific carcinogen NNK induces DNA methyltransferase 1 accumulation and tumor suppressor gene hypermethylation in mice and lung cancer patientsJournal of Clinical Investigation, 2010
- Aberrant promoter methylation of FBLN-3 gene and clinicopathological significance in non-small cell lung carcinomaLung Cancer, 2009
- Differential gene expression identifies subgroups of ovarian carcinomaTranslational Research, 2006
- Epigenetic Therapy of Cancer With 5-Aza-2′-Deoxycytidine (decitabine)Seminars in Oncology, 2005
- Gene Silencing in Cancer in Association with Promoter HypermethylationNew England Journal of Medicine, 2003
- Aberrant DNA Methylation in Lung Cancer: Biological and Clinical ImplicationsThe Oncologist, 2002